Feasibility of weekly participant-reported data collection in a pragmatic randomised controlled trial in primary care: experiences from the BATHE trial (Bath Additives for the Treatment of cHildhood Eczema)

Abstract Background Patient-reported outcomes measures in clinical trials ensure that evaluations of effectiveness focus on outcomes that are important to patients. In relapsing-remitting conditions, such as eczema, repeated measurements may allow a more accurate reflection of disease burden and tre...

Full description

Bibliographic Details
Main Authors: Beth Stuart, Kate Rumsby, Miriam Santer, Matthew J. Ridd, Nick A. Francis, Maria Chorozoglou, Carla Spreadbury, Mary Steele, Claire Nollett, Lyn Liddiard, Martina Prude, Julie Hooper, Emma Thomas-Jones, Amanda Roberts, Kim S. Thomas, Hywel C. Williams, Paul Little
Format: Article
Language:English
Published: BMC 2018-10-01
Series:Trials
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13063-018-2962-3
id doaj-2c0548fefce94cc2a892b25edf2f5dd4
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Beth Stuart
Kate Rumsby
Miriam Santer
Matthew J. Ridd
Nick A. Francis
Maria Chorozoglou
Carla Spreadbury
Mary Steele
Claire Nollett
Lyn Liddiard
Martina Prude
Julie Hooper
Emma Thomas-Jones
Amanda Roberts
Kim S. Thomas
Hywel C. Williams
Paul Little
spellingShingle Beth Stuart
Kate Rumsby
Miriam Santer
Matthew J. Ridd
Nick A. Francis
Maria Chorozoglou
Carla Spreadbury
Mary Steele
Claire Nollett
Lyn Liddiard
Martina Prude
Julie Hooper
Emma Thomas-Jones
Amanda Roberts
Kim S. Thomas
Hywel C. Williams
Paul Little
Feasibility of weekly participant-reported data collection in a pragmatic randomised controlled trial in primary care: experiences from the BATHE trial (Bath Additives for the Treatment of cHildhood Eczema)
Trials
Feasibility
Repeated measures
Trial methodology
Eczema
Atopic dermatitis
POEM
author_facet Beth Stuart
Kate Rumsby
Miriam Santer
Matthew J. Ridd
Nick A. Francis
Maria Chorozoglou
Carla Spreadbury
Mary Steele
Claire Nollett
Lyn Liddiard
Martina Prude
Julie Hooper
Emma Thomas-Jones
Amanda Roberts
Kim S. Thomas
Hywel C. Williams
Paul Little
author_sort Beth Stuart
title Feasibility of weekly participant-reported data collection in a pragmatic randomised controlled trial in primary care: experiences from the BATHE trial (Bath Additives for the Treatment of cHildhood Eczema)
title_short Feasibility of weekly participant-reported data collection in a pragmatic randomised controlled trial in primary care: experiences from the BATHE trial (Bath Additives for the Treatment of cHildhood Eczema)
title_full Feasibility of weekly participant-reported data collection in a pragmatic randomised controlled trial in primary care: experiences from the BATHE trial (Bath Additives for the Treatment of cHildhood Eczema)
title_fullStr Feasibility of weekly participant-reported data collection in a pragmatic randomised controlled trial in primary care: experiences from the BATHE trial (Bath Additives for the Treatment of cHildhood Eczema)
title_full_unstemmed Feasibility of weekly participant-reported data collection in a pragmatic randomised controlled trial in primary care: experiences from the BATHE trial (Bath Additives for the Treatment of cHildhood Eczema)
title_sort feasibility of weekly participant-reported data collection in a pragmatic randomised controlled trial in primary care: experiences from the bathe trial (bath additives for the treatment of childhood eczema)
publisher BMC
series Trials
issn 1745-6215
publishDate 2018-10-01
description Abstract Background Patient-reported outcomes measures in clinical trials ensure that evaluations of effectiveness focus on outcomes that are important to patients. In relapsing-remitting conditions, such as eczema, repeated measurements may allow a more accurate reflection of disease burden and treatment effect than less frequent measurements. We asked parents/carers of children with eczema taking part in a trial of bath emollients to complete weekly questionnaires for 16 weeks. Methods The objective of this study was to determine the acceptability and practicality of collecting weekly measures of eczema severity online for 16 weeks in children aged 1 to 11 years as part of the BATHE study. BATHE randomised patients to bath emollients plus standard eczema care or standard eczema care only. The primary outcome was eczema severity, measured by the seven-item Patient-Oriented Eczema Measure (POEM) repeated weekly for 16 weeks. Acceptability was explored through qualitative interviews with 10 participants. Interviews were audio-recorded, transcribed and analysed thematically. Practicality was assessed by exploring the completeness of the data and keeping a log of any problems. Results Four hundred and eighty-two participants were recruited to the trial and 429 opted to complete measures online (89.0%). Data were collected online for 83% of time points over the 16-week period and there was no association between socio-demographic characteristics and data completeness. Two hundred and six (48%) completed their weekly data every week for 16 weeks and 341 (79%) completed it at least 80% of the time. The mean number of weeks completed was 13.3 out of 16 (SD 4.2). Interviewees said that they understood the rationale behind weekly collection and some welcomed this as it helped them realise how their child’s eczema changed weekly. Whilst some interviewees spoke of weekly questionnaires as onerous, others said that they found them quick and easy. Reminders were welcomed. Parents/carers seemed happy to receive telephone reminders and it was sometimes useful for eliciting problems relating to obtaining trial medication or password problems for online data collection. Conclusions Amongst this population, high levels of data completeness suggests that weekly completion of the online questionnaire appears to be acceptable and feasible over a 16-week period. Trial registration ISRCTN84102309. Registered on 9 December 2013.
topic Feasibility
Repeated measures
Trial methodology
Eczema
Atopic dermatitis
POEM
url http://link.springer.com/article/10.1186/s13063-018-2962-3
work_keys_str_mv AT bethstuart feasibilityofweeklyparticipantreporteddatacollectioninapragmaticrandomisedcontrolledtrialinprimarycareexperiencesfromthebathetrialbathadditivesforthetreatmentofchildhoodeczema
AT katerumsby feasibilityofweeklyparticipantreporteddatacollectioninapragmaticrandomisedcontrolledtrialinprimarycareexperiencesfromthebathetrialbathadditivesforthetreatmentofchildhoodeczema
AT miriamsanter feasibilityofweeklyparticipantreporteddatacollectioninapragmaticrandomisedcontrolledtrialinprimarycareexperiencesfromthebathetrialbathadditivesforthetreatmentofchildhoodeczema
AT matthewjridd feasibilityofweeklyparticipantreporteddatacollectioninapragmaticrandomisedcontrolledtrialinprimarycareexperiencesfromthebathetrialbathadditivesforthetreatmentofchildhoodeczema
AT nickafrancis feasibilityofweeklyparticipantreporteddatacollectioninapragmaticrandomisedcontrolledtrialinprimarycareexperiencesfromthebathetrialbathadditivesforthetreatmentofchildhoodeczema
AT mariachorozoglou feasibilityofweeklyparticipantreporteddatacollectioninapragmaticrandomisedcontrolledtrialinprimarycareexperiencesfromthebathetrialbathadditivesforthetreatmentofchildhoodeczema
AT carlaspreadbury feasibilityofweeklyparticipantreporteddatacollectioninapragmaticrandomisedcontrolledtrialinprimarycareexperiencesfromthebathetrialbathadditivesforthetreatmentofchildhoodeczema
AT marysteele feasibilityofweeklyparticipantreporteddatacollectioninapragmaticrandomisedcontrolledtrialinprimarycareexperiencesfromthebathetrialbathadditivesforthetreatmentofchildhoodeczema
AT clairenollett feasibilityofweeklyparticipantreporteddatacollectioninapragmaticrandomisedcontrolledtrialinprimarycareexperiencesfromthebathetrialbathadditivesforthetreatmentofchildhoodeczema
AT lynliddiard feasibilityofweeklyparticipantreporteddatacollectioninapragmaticrandomisedcontrolledtrialinprimarycareexperiencesfromthebathetrialbathadditivesforthetreatmentofchildhoodeczema
AT martinaprude feasibilityofweeklyparticipantreporteddatacollectioninapragmaticrandomisedcontrolledtrialinprimarycareexperiencesfromthebathetrialbathadditivesforthetreatmentofchildhoodeczema
AT juliehooper feasibilityofweeklyparticipantreporteddatacollectioninapragmaticrandomisedcontrolledtrialinprimarycareexperiencesfromthebathetrialbathadditivesforthetreatmentofchildhoodeczema
AT emmathomasjones feasibilityofweeklyparticipantreporteddatacollectioninapragmaticrandomisedcontrolledtrialinprimarycareexperiencesfromthebathetrialbathadditivesforthetreatmentofchildhoodeczema
AT amandaroberts feasibilityofweeklyparticipantreporteddatacollectioninapragmaticrandomisedcontrolledtrialinprimarycareexperiencesfromthebathetrialbathadditivesforthetreatmentofchildhoodeczema
AT kimsthomas feasibilityofweeklyparticipantreporteddatacollectioninapragmaticrandomisedcontrolledtrialinprimarycareexperiencesfromthebathetrialbathadditivesforthetreatmentofchildhoodeczema
AT hywelcwilliams feasibilityofweeklyparticipantreporteddatacollectioninapragmaticrandomisedcontrolledtrialinprimarycareexperiencesfromthebathetrialbathadditivesforthetreatmentofchildhoodeczema
AT paullittle feasibilityofweeklyparticipantreporteddatacollectioninapragmaticrandomisedcontrolledtrialinprimarycareexperiencesfromthebathetrialbathadditivesforthetreatmentofchildhoodeczema
_version_ 1725478560953532416
spelling doaj-2c0548fefce94cc2a892b25edf2f5dd42020-11-24T23:50:54ZengBMCTrials1745-62152018-10-011911910.1186/s13063-018-2962-3Feasibility of weekly participant-reported data collection in a pragmatic randomised controlled trial in primary care: experiences from the BATHE trial (Bath Additives for the Treatment of cHildhood Eczema)Beth Stuart0Kate Rumsby1Miriam Santer2Matthew J. Ridd3Nick A. Francis4Maria Chorozoglou5Carla Spreadbury6Mary Steele7Claire Nollett8Lyn Liddiard9Martina Prude10Julie Hooper11Emma Thomas-Jones12Amanda Roberts13Kim S. Thomas14Hywel C. Williams15Paul Little16Department of Primary Care and Population Sciences, University of Southampton, Aldermoor Health CentreDepartment of Primary Care and Population Sciences, University of Southampton, Aldermoor Health CentreDepartment of Primary Care and Population Sciences, University of Southampton, Aldermoor Health CentreSchool of Social and Community Medicine, University of BristolWales School of Primary Care Research, Cardiff UniversitySouthampton Health Technology Assessment Centre (SHTAC), University of SouthamptonDepartment of Primary Care and Population Sciences, University of Southampton, Aldermoor Health CentreCentre for Clinical and Community Applications of Health Psychology, Psychology, Faculty of Social and Human Sciences, University of SouthamptonWales School of Primary Care Research, Cardiff UniversitySchool of Social and Community Medicine, University of BristolDepartment of Primary Care and Population Sciences, University of Southampton, Aldermoor Health CentreDepartment of Primary Care and Population Sciences, University of Southampton, Aldermoor Health CentreWales School of Primary Care Research, Cardiff UniversityCentre of Evidence-Based Dermatology, University of NottinghamCentre of Evidence-Based Dermatology, University of NottinghamCentre of Evidence-Based Dermatology, University of NottinghamDepartment of Primary Care and Population Sciences, University of Southampton, Aldermoor Health CentreAbstract Background Patient-reported outcomes measures in clinical trials ensure that evaluations of effectiveness focus on outcomes that are important to patients. In relapsing-remitting conditions, such as eczema, repeated measurements may allow a more accurate reflection of disease burden and treatment effect than less frequent measurements. We asked parents/carers of children with eczema taking part in a trial of bath emollients to complete weekly questionnaires for 16 weeks. Methods The objective of this study was to determine the acceptability and practicality of collecting weekly measures of eczema severity online for 16 weeks in children aged 1 to 11 years as part of the BATHE study. BATHE randomised patients to bath emollients plus standard eczema care or standard eczema care only. The primary outcome was eczema severity, measured by the seven-item Patient-Oriented Eczema Measure (POEM) repeated weekly for 16 weeks. Acceptability was explored through qualitative interviews with 10 participants. Interviews were audio-recorded, transcribed and analysed thematically. Practicality was assessed by exploring the completeness of the data and keeping a log of any problems. Results Four hundred and eighty-two participants were recruited to the trial and 429 opted to complete measures online (89.0%). Data were collected online for 83% of time points over the 16-week period and there was no association between socio-demographic characteristics and data completeness. Two hundred and six (48%) completed their weekly data every week for 16 weeks and 341 (79%) completed it at least 80% of the time. The mean number of weeks completed was 13.3 out of 16 (SD 4.2). Interviewees said that they understood the rationale behind weekly collection and some welcomed this as it helped them realise how their child’s eczema changed weekly. Whilst some interviewees spoke of weekly questionnaires as onerous, others said that they found them quick and easy. Reminders were welcomed. Parents/carers seemed happy to receive telephone reminders and it was sometimes useful for eliciting problems relating to obtaining trial medication or password problems for online data collection. Conclusions Amongst this population, high levels of data completeness suggests that weekly completion of the online questionnaire appears to be acceptable and feasible over a 16-week period. Trial registration ISRCTN84102309. Registered on 9 December 2013.http://link.springer.com/article/10.1186/s13063-018-2962-3FeasibilityRepeated measuresTrial methodologyEczemaAtopic dermatitisPOEM